ImmunologybioRxivPreprint
A vesicle-based platform for high-efficiency, high-viability CRISPR/Cas9 knockout in primary human myeloid cells
Silvia Fiori, Maira Russo, Alice Randon…·Manuel Albanese
This paper develops a vesicle-based CRISPR/Cas9 platform for efficient gene knockout in primary human myeloid cells, preserving viability and enabling downstream functional studies.
DOI 10.64898/2025.12.28.696771